BGM Group Ltd. revenue

BGM Group Ltd.'s revenue was $37.9m in fiscal 2025, up 51.1% on the year before. Since fiscal 2018 ($50.4m) it has grown at a compound -4.0% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

BGM Group Ltd.: revenue history, annual
Fiscal year	2018Sept 2018	2019Sept 2019	2020Sept 2020	2021Sept 2021	2022Sept 2022	2023Sept 2023	2024Sept 2024	2025Sept 2025
Revenue	50	46	50	57	65	46	25	38
Growth on the year before	—	−8.5%	+8.5%	+14.1%	+13.6%	−28.3%	−46.0%	+51.1%
Gross profit	8	10	8	6	6	2	4	6

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
BGM Group Ltd.	$37.9m	51.1%	—
IM Cannabis Corp.	$39.2m	-0.7%	—
Cumberland Pharmaceuticals Inc	$39.9m	-5.2%	-0.6%
Sunshine Biopharma Inc.	$35.3m	-2.7%	34.5%
Scilex Holding Co	$31.6m	-28.5%	-12.0%
Biofrontera Inc.	$46.2m	17.8%	16.7%

Compare with peers

Head to head: BGM vs IMCC BGM vs CPIX BGM vs SBFM

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from BGM Group Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to BGM Group Ltd.